Literature DB >> 23707696

Expression of Clostridium perfringens epsilon-beta fusion toxin gene in E. coli and its immunologic studies in mouse.

Reza Pilehchian Langroudi1, Mehdi Shamsara, Khosrow Aghaiypour.   

Abstract

Clostridium perfringens is an anaerobic spore-forming, pathogenic bacterium that is responsible for severe diseases in humans and livestock. In the present study, an epsilon-beta fusion toxin was expressed as a soluble protein in E. coli and the recombinant cell lysate was used for immunization studies in mouse. Potency of the toxin (as an antigen) induced 6 and 10IU/ml of epsilon and beta anti-toxin in rabbit, respectively. These titers were higher than the minimum level required by the European Pharmacopoeia for epsilon and beta toxins. Experimental challenge with the recombinant fusion toxoid revealed that it could protect mice against C. perfringens epsilon and beta toxins. Toxicity of the fusion toxin was studied by histopathological findings, which were the same as the native toxins. In conclusion, E. coli is a suitable expression host for immunogenic epsilon-beta fusion toxin of C. perfringens.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707696     DOI: 10.1016/j.vaccine.2013.04.061

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

Review 1.  Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines.

Authors:  Marcos Roberto A Ferreira; Gustavo Marçal S G Moreira; Carlos Eduardo P da Cunha; Marcelo Mendonça; Felipe M Salvarani; Ângela N Moreira; Fabricio R Conceição
Journal:  Toxins (Basel)       Date:  2016-11-21       Impact factor: 4.546

2.  Cloning and expression of Clostridium perfringens type D vaccine strain epsilon toxin gene in E. coli as a recombinant vaccine candidate.

Authors:  Parastoo Aziminia; Reza Pilehchian-Langroudi; Kasra Esmaeilnia
Journal:  Iran J Microbiol       Date:  2016-08

3.  Evaluation of plant-produced <i>Clostridium perfringens</i> type D <i>epsilon</i> toxoid in a vaccine against enterotoxaemia in sheep.

Authors:  Tinyiko Mokoena; Ereck Chakauya; Michael Crampton; Boet Weyers; Malefa Tselanyane; Tsepo Tsekoa; Rachel Chikwamba
Journal:  Onderstepoort J Vet Res       Date:  2017-04-25       Impact factor: 1.792

Review 4.  Vaccine Production to Protect Animals Against Pathogenic Clostridia.

Authors:  Nicolas E Zaragoza; Camila A Orellana; Glenn A Moonen; George Moutafis; Esteban Marcellin
Journal:  Toxins (Basel)       Date:  2019-09-11       Impact factor: 4.546

Review 5.  Vaccination against pathogenic clostridia in animals: a review.

Authors:  Lida Abdolmohammadi Khiav; Azadeh Zahmatkesh
Journal:  Trop Anim Health Prod       Date:  2021-04-23       Impact factor: 1.559

6.  Immunogenic and neutralization efficacy of recombinant perfringolysin O of Clostridium perfringens and its C-terminal receptor-binding domain in a murine model.

Authors:  Ankita Singh; Prashant Rawat; Devapriya Choudhury; Aparna Dixit
Journal:  Immunol Res       Date:  2022-01-15       Impact factor: 4.505

7.  Design of a chitosan-based nano vaccine against epsilon toxin of Clostridium perfringens type D and evaluation of its immunogenicity in BALB/c mice.

Authors:  Farnaz Poorhassan; Fahimeh Nemati; Parvaneh Saffarian; Seyed Ali Mirhosseini; Mohammad Javad Motamedi
Journal:  Res Pharm Sci       Date:  2021-10-15

8.  Immunoinformatic analysis of the whole proteome for vaccine design: An application to Clostridium perfringens.

Authors:  Luis F Soto; Ana C Romaní; Gabriel Jiménez-Avalos; Yshoner Silva; Carla M Ordinola-Ramirez; Rainer M Lopez Lapa; David Requena
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

9.  Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.

Authors:  Gustavo Marçal Schmidt Garcia Moreira; Felipe Masiero Salvarani; Carlos Eduardo Pouey da Cunha; Marcelo Mendonça; Ângela Nunes Moreira; Luciana Aramuni Gonçalves; Prhiscylla Sadanã Pires; Francisco Carlos Faria Lobato; Fabricio Rochedo Conceição
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.